Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers

MLA

N. Susumu, et al. “Diagnostic Clinical Application of Two-Color Fluorescence in Situ Hybridization That Detects Chromosome 1 and 17 Alterations to Direct Touch Smear and Liquid-Based Thin-Layer Cytologic Preparations of Endometrial Cancers.” International Journal of Gynecologic Cancer, vol. 15, Jan. 2005, pp. 70–80. EBSCOhost, https://doi.org/10.1136/ijgc-00009577-200501000-00012.

APA

N. Susumu, D. Aoki, T. Noda, Y. Nagashima, T. Hirao, Y. Tamada, K. Banno, A. Suzuki, N. Suzuki, H. Tsuda, J. Inazawa, & S. Nozawa. (2005). Diagnostic clinical application of two-color fluorescence in situ hybridization that detects chromosome 1 and 17 alterations to direct touch smear and liquid-based thin-layer cytologic preparations of endometrial cancers. International Journal of Gynecologic Cancer, 15, 70–80. https://doi.org/10.1136/ijgc-00009577-200501000-00012

Chicago

N. Susumu, D. Aoki, T. Noda, Y. Nagashima, T. Hirao, Y. Tamada, K. Banno, et al. 2005. “Diagnostic Clinical Application of Two-Color Fluorescence in Situ Hybridization That Detects Chromosome 1 and 17 Alterations to Direct Touch Smear and Liquid-Based Thin-Layer Cytologic Preparations of Endometrial Cancers.” International Journal of Gynecologic Cancer 15 (January): 70–80. doi:10.1136/ijgc-00009577-200501000-00012.